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ABSTRACT  
Background The generic preference-based measures (GPBMs) have been 
widely used to obtain health utility scores for calculating Quality Adjusted Life 
Years (QALYs) for economic evaluations. It has been recognized that 
GPBMs may miss relevant or important dimensions for some specific 
conditions. Objective The objective of this study is to explore the effect of 
extending the current EQ-5D descriptive system by adding a sleep dimension. 
Methods $QHZLQVWUXPHQW³(4-'6OHHS´ LVSURSRVHGE\DGGLQJDVOHHS
dimension to the EQ-5D.  Based on an orthogonal design, 18 EQ-5D+Sleep 
states and EQ-5D states were selected and a valuation study was 
undertaken interviewing 160 members of the generic public in South 
Yorkshire using time trade-off (TTO). Econometric models have been fitted to 
the data. Two null hypotheses were tested: 1) the coefficient for the sleep 
dimension is not significant; and 2) the inclusion of the sleep dimension has 
no impact on the way people value the other dimensions so that the 
coefficients of the original dimensions levels remain unaffected. Results and 
conclusions The results support these two null hypotheses. There seems to 
be no benefit to adding a sleep dimension to the EQ-5D. Research is 
required to explore the methodology of adding on dimensions to existing 
descriptive systems of health.  
 
Key words: EQ-5D, add-on, sleep, health state valuation, QALYs 
(207 words) 
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1. INTRODUCTION  
Quality Adjusted Life Years (QALYs) have become a widely used measure of 
health in economic evaluations to inform decisions regarding different health 
technologies and interventions. A common approach is to use one of the 
generic preference-based measures (GPBMs) of health to obtain health utility 
scores for the calculation of QALYs. It has been claimed that GPBMs are 
applicable to interventions across different patient groups, and consequently 
ensure comparability between interventions across different medical 
conditions and treatments. (1-3)  
 
Yet, GPBMs may not be applicable to all interventions across all patient 
groups. A key concern is that GPBMs may miss relevant or important 
dimensions for some specific conditions. Generic measures, including those 
that are preference-based, are intended to cover all important dimensions of 
health(1). In practice, however, it is not possible for a measure to address all 
relevant dimensions of health in their descriptive system to ensure full 
coverage. For preference-based measures requiring valuation, this is a more 
obvious problem due to the limited amount of information (e.g. number of 
dimensions of a measure) individuals are able to handle for valuation. The 
widely used GPBMs, such as EQ-5D,(4)  SF-6D (5) and Health Utility Index 3 
(HUI3) (6)  typically contain 5 to 8 dimensions to cover the core (but not all) 
aspects of health. It has been shown that the EQ-5D descriptive system, for 
example, is insensitive to changes in conditions such as hearing impairment  
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(7) 
 and visual problems (8;9) and this may be due to inadequate coverage of its 
descriptive system. An inadequate measure may result in a misallocation of 
resources.  
 
In order to address the limited relevance of GPBMs, an alternative approach 
would be to develop condition-specific preference-based measures of health 
(CSPMBs) for calculating QALYs.  CSPBMs have been developed for a wide 
range of conditions, such as asthma,(10) sexual diseases,(11) and bladder 
diseases. (12;13)  These condition specific measures have raised fundamental 
concerns as to whether they can be used to make comparisons between 
interventions for different conditions.(14) CSPBMs have also been criticized 
because they may fail to pick up side-effects of treatment, and effects on co-
morbidities alongside the condition. Furthermore, valuation of CSPBMs may 
EHPRUHSURQHWKDQ*3%0VWRµIRFXVLQJHIIHFWV¶ZKHUHE\UHVSRQGHQWV focus 
on and exaggerate the importance of the particular problems described and 
give larger weights to them than they would in the wider context of their 
overall health. (14) 
 
Given these issues, it seems worthwhile to explore the use of GPBMs as a 
starting point, and to add items to existing generic measures to improve the 
relevance to a specific condition. Little attempt has been made to explore 
such an approach to date. To the best of our knowledge, 3 studies offer 
comparisons between the EQ-5D against a 6- or 7-dimension instrument that 
nests it, of which only one is published. First, the original EuroQol instrument 
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can be interpreted as an EQ-5D with an energy/tiredness dimension added , 
(15)
 Dowie  (1999, Health Economist Study Group conference paper, 
unpublished manuscript) proposed to add 2 extra dimensions to the EQ-5D 
questionnaire where one dimension concerned bother from symptoms, and 
the other dimension concerned bother from treatments. Third, in the same 
year, Krabbe and his colleagues(16)  published an article examining the 
impact of adding a dimension for cognition to the EQ-5D questionnaire. The 
resulting EQ-5D+C value set was validated in a population with cognitive 
impairments by Wolfs and her colleagues.  (17)  
 
The main aim of our VWXG\ ZDV WR H[DPLQH WKH LPSDFW RI DGGLQJ D µVOHHS¶
dimension to the descriptive system of the EQ-5D.  
 
2. :+<$''µ6/((3¶727+((4-5D? 
It has long been observed that the quantity and quality of sleep influence 
SHRSOH¶Vself-perceived health, and productivity and performance in society. 
Sleep problems may include: difficulties falling asleep, waking during the 
night, waking early and being unable to go back to sleep again and waking in 
the morning feeling unrefreshed.(18) Clinicians have observed that sleep 
problems are commonly associated with medical conditions like asthma, or 
urinary impairment and their treatment. However, sleep problems are also 
common within the general population. For instance, Groeger et al (18) 
showed that amongst a representative sample of 2000 British adults, 58% 
reported sleep problems on one or more nights in the previous week.  The 
6 
 
corresponding figures for 1010 Americans by gender are 63% for women and 
54% for men.(19)  
 
Sleep can have an impact on Subjective Well-being (SWB) where SWB is 
GHILQHGDVSHRSOH¶Vself-reported satisfaction with their own life. For instance, 
studies have suggested that poorer sleep associated with leads to poorer 
day-to-day emotional well being (20) and lower global levels of life 
satisfaction.(21; 22). These results are in line with the assumption that the effect 
of sleep matters RQ SHRSOH¶V ZHOO-being, and support adding sleep as a 
dimension to a health related quality of life instrument. In fact, GPBMs such 
as 15D (23) and the Assessment of Quality of Life (AQoL) instruments,(24) and 
CSPBMs such as OAB-5D for overactive bladder (12) and AQL-5D for asthma 
(25)
  FRQWDLQ D µVOHHS¶ GLPHQVLRQ LQ WKHLU GHVFULSWLYH V\VWHPV 7KH :RUOG
Health Organization Quality of Life instrument (WHOQoL-100) also contains 
2 sleep-related items. (26)  
 
The EQ-5D was selected as the GPBM to build on because it is the 
instrument of choice by the National Institute of Health and Clinical 
Excellence (NICE) in the UK and has been used most widely in economic 
evaluations. Secondly, it only has 5 dimensions making it easier to add to, 
compared to the larger descriptive systems like the SF-6D and HUI3 with 6 
and 8 dimensions respectively.  Furthermore, sleep is not covered by the EQ-
5D descriptive system although it was developed as a multi-attribute 
classification system covering the full health spectrum, indicating physical, 
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mental and social function, to ensure its use across a wide range of health 
interventions. (4) Given the impact of sleep on SHRSOH¶VTXDOLW\RIOLIHLWPDNHV
a good candidate to add to the EQ-5D in order to explore the effect of 
extending the current EQ-5D.  
 
The question is whether sleep has a significant impact on the value of the 
health states and if so, what the nature of the impact is.  Adding a sleep 
dimension can impact on health state values through significant coefficients 
for having sleep problems.  It may also have an impact on the weight given to 
the other dimensions of the EQ-5D so that the coefficients for having 
problems in the original 5 dimensions may be affected.  Our research tests 
these potential impacts using a rigorously designed valuation survey of the 
general public using an established choice-based valuation technique. 
 
3. METHODS 
A valuation study of the EQ-5D+Sleep instrument was conducted using a 
modified Measurement and Valuation of Health (MVH) Time Trade-off (TTO) 
protocol. (27) Half the respondents were asked to value hypothetical health 
states described using the standard EQ-5D instrument without the sleep 
dimension, the other half to value hypothetical EQ-5D+Sleep states, and their 
values compared. Econometric models were estimated to predict values for 
every health state defined by the 2 descriptive systems. The model 
coefficients for the EQ-5D and the EQ-5D+Sleep were examined and 
compared to test 2 null hypotheses:  
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--- the sleep dimension does not have significant impact on health state 
values (so the coefficients for the sleep dimension are not significant in the 
EQ-5D+Sleep model); and 
--- the inclusion of the sleep dimension in EQ-5D+Sleep has no impact on the 
way people value the original dimensions of the EQ-5D descriptive system 
(so that the absolute values of the coefficients of the 5 original dimensions of 
the EQ-5D+Sleep model are no smaller than the corresponding coefficients 
of the EQ-5D model).  
 
3.1 INSTRUMENTS AND THE SELECTION OF STATES 
EQ-5D:  The EQ-5D descriptive system contains 5 dimensions: mobility, self-
care, usual activities, pain/discomfort and anxiety/depression. In its most 
widely used form, each dimension has 3 levels denoting no problems (level 
1), moderate problems (level 2) and extreme or severe problems (level 3). 
This 5-dimension and 3-level health classification system defines a total of 
243 (calculated as 35) health states. (28) The most widely used scoring 
algorithm for the EQ-5D was estimated by the MVH group at the University of 
York using a TTO protocol. (29)  
EQ-5D+Sleep:  The EQ-5D+Sleep is an extension of the standard EQ-5D 
descriptive system. A sleep dimension was added to the EQ-5D as the 6th 
dimension which consists of the following 3 levels to ensure consistency with 
the existing dimensions: 
--- (level 1) I have no problems with sleep 
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--- (level 2) I have some problems with sleep 
--- (level 3) I have extreme problems with sleep  
 
This 6-dimension and 3-level health classification system defines a total of 
729 (calculated as 36) health states. Each state can be described using a 6-
digit code indicating the level at each of the 6 dimensions.  
 
Orthogonal designs generated using SPSS version 15 (SPSS, Inc, an IBM 
Company, Chicago IL) indicated that for a 5-dimensional 3-level instrument 
(EQ-5D) and a 6-dimensional 3-level instrument (EQ-5D+Sleep), an additive 
model can be estimated based on valuations of 18 states each. The best 
state defined by the instrument (state 11111 for EQ-5D and state 111111 for 
EQ-5D+Sleep) were included in both sets. As these best states were going to 
be used as the upper anchors in the TTO valuation task, 17 intermediate 
states were selected for valuation. For each instrument, the intermediate 
states were stratified into severity groups based on their total level scores 
across the dimensions and then randomly allocated to blocks of either 8 or 9 
states, resulting in 2 EQ-5D blocks and 2 EQ-5D+Sleep blocks.  Then the 
µSLWV¶ RU WKHZRUVWSRVVLEOH VWDWH  IRU(4-5D and 333333 for EQ-5D-
Sleep) of each instrument was added to each block.  
 
Among the health states suggested by the orthogonal design, there were 6 
µPDWFKHG KHDOWK VWDWH SDLUV¶ DFURVV WKH  (4-5D and EQ-5D+Sleep states, 
where a matched pair contained an EQ-5D state and a corresponding EQ-
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5D+Sleep state consisting of the same EQ-5D profile plus any given level of 
the extra sleep dimension.  The 6 matched health state pairs were: 11233 vs. 
112331, 22232 vs. 222321, 12312 vs. 123122, 33132 vs. 331322, 31211 vs. 
312113, and 33333 vs. 333333. It can be seen that 2 states add sleep at 
level 1, 2 states add sleep at level 2, and a further 2 states add sleep at level 
3. The health state values of these matched state pairs can be compared to 
determine the impact of adding the sleep dimension. 
 
3.2 THE INTERVIEWS 
The main part of the study consisted of a valuation survey of selected EQ-5D 
states and EQ-5D+Sleep states among members of the public in South 
Yorkshire, UK (adults over 18 years old). The first stage of recruitment was to 
select a sample of streets within South Yorkshire using the ADF Names and 
Numbers database (ADF Software Limited, Ramsey, UK, available from 
http://www.afd.co.uk/product_namesandnumbers.asp) which provides access 
to names and addresses for over 39 million people in the UK. The sampling 
aimed to achieve a good spread across age, gender, ethnicity and social class. 
An information sheet was then sent to all household addresses on the 
sampled streets explaining the project in plain language and inviting their 
participation. In the next stage, an interviewer knocked on the doors of 
UDQGRPO\VHOHFWHGKRXVHKROGVWRREWDLQWKHUHVLGHQW¶VFRQVHQWWRSDUWLFLSDWH, 
and either interviewed the resident immediately or arranged a convenient 
time to revisit for the interview. There was no limit to the number of interviews 
conducted in a selected household.  
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There is little guidance available on how many observations are required per 
health state in order to model health state valuations. Given the budget 
constraints, the sample size for the valuation survey was limited to 160 
interviews. The respondents were randomly divided into 4 groups of 40: and 
each group was assigned one of the 4 health state blocks explained above. 
In this way, each intermediate state was valued 40 times, which is 
reasonable compared to the average of 15 times per state for the SF-6D 
valuation study (5) or the average of 24 times for the UK HUI survey (30) given 
that the classification systems of SF-6D and HUI are much larger than that of 
EQ-5D or EQ-5D+Sleep. The pits states were valued 80 times each. 
 
The interviews were based largely on the MVH valuation protocol, (29) and 
included self-reported health status using either EQ-5D or EQ-5D+Sleep (the 
instrument they are valuing), ranking of hypothetical states, and a valuation 
exercise using Time Trade Off (27), followed by personal background 
questions. Those respondents valuing EQ-5D states were given an extra 
question using the sleep dimension of the EQ-5D+Sleep as part of the 
background questions at the end of the interview.  
 
3.3 THE ANALYSIS 
The background characteristics of the 2 groups of respondents who valued 
the EQ-5D and the EQ-5D+Sleep descriptive systems were compared. A 
Chi-square test was performed to examine whether there was any difference 
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between the 2 samples in terms of age group, gender, or self-reported health 
status. For oUGHUHG YDULDEOHV HJ DJH JURXSV ¶-¶ ¶-¶ µ36-¶ HWF
and self-reported EQ-' GLPHQVLRQV IURP µ¶ RI µQR SUREOHPV¶ µ¶ RI
PRGHUDWH SUREOHPV DQG µ¶ RI µH[WUHPH SUREOHPV¶ WKH &KL-square Gamma 
statistic was undertaken to make adequate use of the relevant information.  
  
The TTO valuations derived for the health states defined by the 2 descriptive 
systems were transformed following Dolan (31)  which ensures all health state 
values are bound between (-1) and (+1). The number of observations, mean 
transformed TTO values and standard deviations, and maximum and 
minimum values are reported for the 2 instruments. The t-tests were 
performed to test for significant differences between the 6 matched health 
state pairs across the 2 instruments.   
 
The next stage was to model the health state values of EQ-5D and EQ-
5D+Sleep on the basis of the valuation data directly obtained from the survey. 
The main purpose of modelling here is to compare the model coefficients to 
test the 2 null hypotheses above. STATA version 9 (StataCorp, College 
Station, TX) was used for all regression analysis.  
 
 
The general model is defined as:   
   (1) 
ij j įȜ 
 
įȜ ij g y H G T E  c  c  c   ) ( z r x 
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Where: 
yij: transformedTTO scores for health state i valued by respondent j 
      i  «QUHSUHVHQWVLQGLYLGXDOKHDOWKVWDWes 
     j  «PUHSUHVHQWVUHVSRQGHQWV 
g: a function specifying the appropriate functional form 
x: a vector of binary dummy variables for each level Ȝof dimension į of the 
classification of EQ-5D or EQ-5D+Sleep  
r: a vector of terms to account for interactions between the levels of different 
dimensions of EQ-5D or EQ-5D+Sleep 
z: a vector of personal characteristics including UHVSRQGHQW¶V JHQGHU DJH
self-reported health (individual EQ-5D dimensions and sleep), education and 
household status.  
İij: an error term whose autocorrelation structure and distributional properties 
depend on the assumptions underlying the particular regression model used.  
 
A range of models were considered and the ultimate choice of model 
specification was based upon the features of the valuation data obtained. An 
ordinary least squares (OLS) regression using individual level TTO values 
would assume that each health state value is independent, ignoring the fact 
that multiple health state valuations have been given by the same 
respondent so that health state values may be  clustered by respondents.  A 
potentially better specification is the one-way error components random 
effects (RE) model which takes account of the clustering of data by 
respondents and allows for the fact that the error term may not be 
independent of the respondent ± it separates out error terms both within and 
between respondents. The RE model also assumes that the error term for 
any health state valuation by an individual is random. The RE model 
14 
 
VSHFLILFDWLRQKDVSUHYLRXVO\EHHQVXFFHVVIXOO\HVWLPDWHGDQGFKRVHQDVµWKH
EHVW PRGHO¶ IRU (4-5D valuation data obtained from the UK general 
population (29) and in several other cases. (32;33) Therefore for the current 
study, a one-way error components RE model using individual level data was 
estimated for each of the 2 descriptive systems using maximum likelihood 
estimation. 
 
In order to ensure that the coefficients of the level 2 and level 3 dummies 
would have a more intuitive interpretation, decrements in utility from full 
health are modelled, by using the difference between 1 and the TTO value as 
the dependent variable. If a respondent values a health state as worse than 
being dead, the associated disutility would be larger than 1.  Thus, the level 2 
and level 3 coefficients are expected to be positive, and with level 3 having a 
larger coefficient.  
 
Interaction terms between all the different levels of all the dimensions of EQ-
5D or EQ-5D+Sleep were not feasible due to the relatively small sample size. 
Further, the health state selection was based on a linear additive model. 
Therefore, only Interaction terms between the sleep and the EQ-5D 
dimensions were examined when the EQ-5D dimensions showed significant 
change of coefficients after the inclusion of the sleep dimension (see next 
paragraph).   
 
After the model estimation, the coefficients of the EQ-5D and EQ-5D+Sleep 
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models were compared to test the 2 null hypotheses presented above. The 
first hypothesis was straightforward, while the second hypothesis was 
examined by means of a comparison between the modelled coefficients for 
the 5 original EQ-5D dimensions and those for EQ-5D+Sleep using a series 
of z-tests for the 10 corresponding beta coefficients (see equation 2) with a 
0.10 significance level (34;35).            
           
22 )()( SE
SE
SESE
z
GJGO
GOGOGO
EE

 
                                                                       (2)                
Beta: regression coefficient  
SE: standard error of coefficient 
E: EQ-5D 
S: EQ-5D+sleep 
 
 
 
4. RESULTS 
4.1     SAMPLE BACKGROUND CHARACTERISTICS 
The EQ-5D and EQ-5D+Sleep valuation survey was undertaken between 
June and September 2007. Nine hundred invitation letters were mailed out. 
From these, a total of 160 members of the public were successfully 
interviewed (80 for EQ-5D and 80 for EQ-5D+Sleep) and their data included 
in subsequent analysis.  Recruitment information is reported in Table 1, 
including a response rate of 51% amongst those eligible (i.e. those at home 
and suitable for interview). 
                                              {Insert Table 1 here} 
The personal characteristics of the 2 samples that valued EQ-5D and the 
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EQ-5D+Sleep are reported in Table 2. In general, the 2 samples were 
comparable in terms of age, gender, education and social-economic status. 
The results of the Chi-square test suggested that there was no significant 
difference between the 2 samples in terms of age, gender and health status 
(P>0.1). The 2 samples had similar health status as described by the EQ-5D, 
but more respondents in the EQ-5D sample suffered from moderate sleep 
problems than in the EQ-5D+Sleep sample (33/80 vs. 20/80;p<0.1).  
                                              {Insert Table 2 here} 
 
4.2    TTO HEALTH STATE VALUES  
A total of 1512 TTO values were elicited from the 161 respondents in the 
interview survey with 770 values for the 18 EQ-5D states and 742 values for 
the 18 EQ-5D+Sleep states. Descriptive statistics are presented in Table 3, 
where health states are ranked according to their mean TTO values.  
                                              {Insert Table 3 here} 
Transformed TTO values at the individual level ranged from -0.98 to 1.00. In 
terms of mean TTO values, EQ-5D values had a range of -0.227 (state 
33333) to 0.609 (state 12312), while EQ-5D+Sleep values ranged from -
0.233 (state 333333) to 0.764 (state 211223). The standard deviations of 
EQ-5D states were from 0.35 to 0.63 with an average of 0.52, while for the 
EQ-5D+Sleep states these ranged from 0.30 to 0.50 with an average of 0.43.  
Across the 2 instruments, less severe health states with higher values tended 
to have smaller standard deviations.  
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A significant difference between the matched EQ-5D and EQ-5D+Sleep 
states was only found for health states pair 11233 (mean value 0.18) vs. 
112331 PHDQ YDOXH  ZKHUH µQR SUREOHP¶ LQ VOHHS ZDV DGGHG WR D
generally moderate EQ-5D state (p<0.1). However, no statistically significant 
differences were found for mean values of the other pairs, namely, 22232 
(mean value 0.44) vs. 222321(mean value 0.31); 12312 (0.609) vs. 123122 
(0.591); 33132 (0.093) vs. 331322 (0.171); 31211 (0.375) vs. 312113 (0.393); 
and 33333 (-0.227) vs. 333333 (-0.233); where various levels of the sleep 
dimension were added to relatively moderate or severe EQ-5D states. For 
those pairs without significant differences, no obvious pattern was found. The 
implication here seems to be that, in most cases, adding an extra sleep 
dimension to the EQ-' V\VWHP GRHV QRW FKDQJH SHRSOH¶V YDOXHV
significantly. This was examined further by modelling the data as reported 
below.  
 
4.3    HEALTH STATES MODELLING 
The results of modelling are presented in Table 4, where models (E1) and 
(S1) are main effects models for EQ-5D and EQ-5D+Sleep respectively, and 
models (E2) and (S2) include respondents` socio-demographic variables.  
                                              {Insert Table 4 here} 
The EQ-5D main effects model (E1) had coefficients in agreement with the 
ordinality of the EQ-5D health state classification. All coefficients had the 
expected positive sign except for level 2 of self-care but this coefficient was 
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not statistically significant (p>0.1)  so it is a weak inconsistency. Overall, 7 
out of a total of 10 main effects coefficients in model E1 were statistically 
significant (p<0.1) with the expected sign. All the coefficients for level 3 
(extreme) problems were significant, but for level 2 only usual activity and 
pain/discomfort coefficients were significant.  
 
In most cases, the EQ-5D+Sleep main effects model (S1) had coefficients in 
agreement with the ordinality of the EQ-5D+Sleep health state classification. 
All coefficients had the expected positive sign except for level 2 for 
anxiety/depression and level 2 for sleep. For level 2 of anxiety/depression, it 
was not statistically significant (p>0.1) so it is a weak inconsistency. Of the 
sleep coefficients, only level 2 was significant (p=0.08) coefficient, but with an 
unexpected sign. Overall, 8 out of the 12 main effects coefficients in model 
S1 were statistically significant, with the expected sign. The 3 non-significant 
coefficients are level 2 pain/discomfort, level 2  anxiety/depression, and level  
3  sleep.  
 
Comparing the EQ-5D main effects model E1 with the corresponding EQ-
5D+Sleep model S1, 7 out of 10 coefficients of the EQ-5D model were 
significant (p<0.1) with the expected sign, while 8 out of 12 coefficients were 
significant with the expected sign in the EQ-5D+Sleep model. Within each 
descriptive system, the regression coefficients were logically ordered, with 
the exception of the sleep coefficients. Both models showed that extreme 
problems in the mobility dimension contributed to the most disutility. In terms 
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of the least disutility caused by a level 3 problem, this was the usual activity 
dimension in the EQ-5D model and the sleep dimension in the EQ-5D+Sleep 
model. The EQ-5D model had a constant term of 0.281 while the EQ-
5D+Sleep model had a smaller constant term of 0.146.   
 
Generally, the coefficients of the 2 models were comparable as their 
differences were small (e.g. 0.315 vs. 0.307 in the mobility dimension). The 
exception was the self-care dimension which had a difference larger than 0.1 
(0.122 vs. 0.259). The results of z-tests between the corresponding 
coefficients of the 2 models quantitatively supported this conclusion. Only the 
coefficients of the self-care dimension were statistically significantly different 
across the models. For both level 2 and level 3 self-care, the coefficient in the 
S1 model is larger than the coefficient in the E1 model, indicating that the 
inclusion of the sleep dimension increased the impact of the self-care 
dimension on TTO values. Interactions between the self-care and sleep 
dimensions were examined.  Four interaction terms were included in the 
model (selfcare2 * sleep2, selfcare2 * sleep3, selfcare3 * sleep2, and 
selfcare3* sleep3), but none of the associated coefficients was statistically 
significant(P<0.1).  
 
RespondHQWV¶ DJH JHQGHU HGXFDWLRQ KRXVHKROG VWDWXV DQG VHOI-reported 
health (in EQ-5D dimensions and sleep) were introduced into the EQ-5D and 
the EQ-5D+Sleep models (models E2 and S2) in order to control for any 
differences between the 2 samples and capture effects of covariates.  The 
results show that none of these coefficients were significant in the EQ-5D 
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model, and for the EQ-5D+Sleep model, none but 3 (of the 5) age group 
coefficients were statistically significant. For either model, the inclusion of 
covariates  rarely changed the coefficients of the original models, apart from 
the constant term of the EQ-5D model which decreased  from 0.281(p<0.1) 
to -0.423 (p>0.1). The constants of both the EQ-5D and the EQ-5D+Sleep  
models went from statistically significant to non-significant by including 
covariates. 
 
5   DISCUSSION AND CONCLUSION 
5HFRJQLVLQJ WKH LPSRUWDQFH RI VOHHS IRU SHRSOH¶V TXDOLW\ RI OLIH WKLV VWXG\
attempted to examine the effect of adding a sleep dimension onto the original 
EQ-5D descriptive system.  The evidence did not support the hypothesis that 
the sleep dimension makes a significant impact on the values people place 
on the EQ-5D. First, among the 6 matched health state pairs, adding a sleep 
dimension did not change the EQ-5D values significantly in most cases. 
Secondly, when health state values were modelled, sleep was the only 
dimension with a non-significant level 3 coefficient. Thirdly, adding a sleep 
dimension did not induce significant changes to the coefficients of most EQ-
5D dimensions. The conclusion holds true when respondents` socio-
demographic characteristics were introduced into the models.  
 
These findings were not expected, DVµVOHHS¶ZDVIRXQGWREHLPSRUWDQWLQWKH
well-being literature. However, the results above need not be regarded as 
incompatible with the findings in the well-being literature.  First, people may 
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not realise the impact of sleep problems on well-being, and thus may not 
regard having sleep problems as something worth giving up survival for.  
Alternatively, even if people realise the impact of sleep problems on well-
being, if they think the impact is already captured adequately by the EQ-5D, 
then there may be no further residual impact worth trading survival for. For 
example, impaired sleep may have been reflected in impaired mobility (e.g., 
poor balance/reflexes), impaired usual activity (e.g. slow response), and 
anxiety/depression problems. Qualitative research could be a useful way to 
explore these issues. On the other hand, the current findings echo the 
EuroQoO*URXS¶VHDUO\ILQGLQJVXVLQJversion of their instrument consisting 6  
dimensions:  the non-VLJQLILFDQW µHQHUJ\¶GLPHQVLRQZDVHYHQWXDOO\GURSSHG
to form the current EQ-5D instrument. (15)  Sleep may strongly correlate with 
energy. At the same time, the SF-6D (5) FRQWDLQV D µYLWDOLW\¶ GLPHQVLRQ
described DVµKDYLQJDORWRIHQHUJ\DOORIWKHWLPHPRVWRIWKHWLPHHWF¶DQG
while the coefficients of this vitality dimension in the SF-6D model are 
significant, they are smaller in size compared to the other dimensions.  
 
There were 2 exceptions regarding the general non-significant impact of the 
sleep dimension. One was the matched health state pair 11233 vs. 112331 
ZKHUH VSHFLI\LQJ µQR VOHHS SUREOHP¶ UHVXOWHG LQ WKH KHDOWK VWDWH YDOXH
significantly increasing from 0.179 (11233) to 0.486 (112331). It may be that 
people valued the ability to sleep well under extreme pain/discomfort and 
anxiety/depression, because problem-free sleep would be a form of relief 
from pain/discomfort and anxiety/depression. Alternatively, respondents may 
have imagined poor sleep would result from the original EQ-5D state and so 
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adding level 1 for sleep improved the state. However, when level 1 sleep was 
added to EQ-5D state 22232 (e.g. reflecting extreme pain/discomfort and 
moderate problems in other dimensions) to form EQ-5D+Sleep state 222321, 
the 2 states were not found to be statistically significantly different from each 
other.  
 
Another exception was found via model estimation. While most coefficients 
are unaffected, the self-care dimension exhibited significantly different 
coefficients with or without the sleep dimension: and this pattern remained 
when respondents¶ socio-demographic variables were introduced to the 
models. It is possible that interactions between the self-care and sleep 
dimensions exist. This was tested by creating interaction terms between 
these 2 attributes (self-care × sleep), but none of the coefficients was   
statistically significant. However, it should be noted that the study design only 
allows the estimation of additive models and possibly a larger valuation study 
with more states is needed for further examination of interactions.  
 
This finding also provides evidence to challenge the assumption that the 
impact of different dimensions on preferences is additive. If the assumption 
holds, inclusion or exclusion of a sleep dimension (or any dimension) should 
lead to no significant change in the coefficients of the other dimensions in the 
classification. The non-additivity between dimensions was also observed in a 
recent study of adding on a pain dimension to an asthma-specific utility 
measure, the AQL-5D.(36) The possibility of non-additivity of dimensions 
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creates a further challenge in the development of the add-on approach 
because if the relationship between dimensions of health is not additive, then 
it would be problematic to have a core value set of a preference-based 
measure (such as EQ-5D) and then to simply add relevant dimensions and 
their associated decrements on to it. It may be possible to use multiplicative 
interaction terms to solve this problem but this requires a larger design and 
would have to be repeated for each potential dimension to be added . 
 
While a simple comparison of values across health states with and without 
the extra dimension gives an indication of whether this has an impact, in 
order to conduct a systematic comparison across the 2 descriptive systems 
and their values, there needs to be a statistically designed survey with 
modelling to estimate the impact of the additional dimension through its 
coefficients and those of the other dimensions. The main contribution of this 
study has been in showing how add-on studies might be performed.  
3UHYLRXVO\ LQ WKH OLWHUDWXUH QR YDOXDWLRQ VWXG\ ZDV XQGHUWDNHQ LQ 'RZLH¶V
work, and the impact of the 2 dimensions on EQ-5D values was ultimately 
determined through an arbitrary estimation (5% or 10% reduction of the EQ-
5D tariff for moderate or extreme bother respectively, for each additional 
dimension). A problem shared by the testing of the energy dimension in the 
original EuroQol Instrument and the testing of the cognition dimension in the 
EQ-5D+C instrument is that both studies used VAS to value the selected 
health states, rather than a choice-based technique (i.e. Time Trade Off or 
Standard Gamble); and the health states selected for valuation were not 
based on a statistical design so there was no formal estimation of the impact 
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on the overall utility function. Furthermore the only published valuation study 
for an add-on, for the EQ-5D+C, was undertaken using a convenience 
sample of academic and managerial staff at a university and so is not likely to 
be representative of the general population. Therefore, our study is the only 
one to date that has examined the impact of adding a dimension to a generic 
measure, based on values obtained from members of the general population 
using a choice-based technique and one that examined the implications for 
the overall utility function. 
 
This study has a number of limitations. The first is the choice of the sleep 
dimension. Specifically, problems with sleep could be related to sleep 
disturbance or sleep-related impairment and these could be considered 
distinct. Qualitative interviews with members of the general public would help 
to elucidate this but was not undertaken in the current study. Second, the 
sample size of the current study was relatively small for estimating a full 
PRGHO IRU YDOXLQJ KHDOWK VWDWHV 7KLV PD\ OLPLW WKH VWXG\¶V DELOLW\ WR GHWHFW
important differences. Nevertheless, these limitations cannot undermine the 
methodological contribution of the study to the development of add-ons.   
 
For future add-on studies, it is important to examine and choose the 
dimension(s) to be added to a measure with care. A literature review on the 
performance of GPBMs in different conditions may suggest possible missing 
dimensions to add. On the basis of systematic reviews of validity and 
responsiveness of EQ-5D, vision was suggested as a potential candidate for 
future add-on studies (8) Mapping functions between (non-preference based) 
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condition-specific measures onto GPBMs may also provide information on 
candidate dimensions to add. Those dimensions that perform poorly in 
mapping regressions are in effect missing from the GPMBs, and therefore 
can be regarded as potential candidates for add-ons. Finally, qualitative 
interviews of patients and/or clinicians could be used to identify possible 
candidates of add-on dimensions.  
 
Because of its brevity, EQ-5D may miss important dimension(s) of health, 
and it has been argued that the add-on approach may to some extent offer a 
solution. This study provides the most robust empirical test of the add-on 
approach to date through TTO valuations with and without the add-on using 
econometric models to examine the impact of the extra dimension on the 
overall preference function for EQ-5D. This rigorous approach needs to be 
extended to other possible candidate dimensions to add  Larger sets of 
health states and respondent samples are necessary to ensure sufficient 
power to examine interactions between health dimensions, especially 
between the original and the added dimensions.    
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Table 1     Recruitment information for the valuation survey                                
                    
Letters of invitation sent                                                                       900 
Letters returned from vacant properties                                                12 
Refusals at this stage                                                                              0 
Properties called where residents were not at home                          433 
Refusals when interviewer called                                                        154 
Respondents unsuitable for interview*                                                  53 
1XPEHURIRWKHUUHDVRQVIRULQWHUYLHZQRWJRLQJDKHDG  56 
Partially completed interviews                                                                 2 
Completed interviews                                                                           160 
 
*The resident was deemed unsuitable if under 18 years old or they had a disability 
preventing them from completing the survey. 
 
1XPEHURIRWKHUUHDVRQVIRULQWHUYLHZQRWJRLQJDKHDG
XVXDOO\PHDQVWKDWWKH
interviewer could not carry out an interview when they visited the address, but there 
was a possibility of carrying out an interview at that address at another time. This 
could be because the resident stated they could not do the interview on this occasion 
but could on another visit, or were unsure if they wanted to do the interview and 
requested the interviewer to call back another time, or the person in the house at the 
time was not suitable (e.g. a child) but the interviewer might have been able to carry 
out an interview with another resident of the house at another time.  
 
Response rate1 = successful interviews / basic sample 
                = 160 / (900 ± (addressed vacant + unsuitable respondents)) 
                = 160 / (900± (12 + 53)) 
                = 160 / 835 = 19 % 
Response rate2 
  =successful interviews / total number of eligible respondents 
  =160 / (successful interviews + total number of respondents refusing to participate) 
  =160 / (160 + 154) =160 / 314= 51% 
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Table 2  Personal characteristics of the respondents 
 
EQ-5D sample 
(N=81) 
EQ-5D+Sleep 
sample (N=80) 
Gender Female 58  52 
 Male  23 28 
Age 18-25 7 4 
 26-35 13 15 
 36-45 15 18 
 46-55 18 11 
 
56-65                           16 16 
66- 10 15 
Self reported 
EQ mobility 
No problems 64 66 
Moderate problems 17 14 
Extreme problems 0 0 
Self reported 
EQ self care 
No problems 80 76 
Moderate problems 1 4 
Extreme problems 0 0 
Self reported  
EQ usual activities 
No problems 68 67 
Moderate problems 12 12 
Extreme problems 1 1 
Self reported 
EQ pain/discomfort 
No problems 49 51 
Moderate problems 29 23 
Extreme problems 3 5 
Self reported  
EQ anxiety/depression 
No problems 66 66 
Moderate problems 14 12 
Extreme problems 1 1 
Self-reported sleep* 
No problems 41 56 
Moderate problems 33 20 
Extreme problems 3 3 
Education after minimum 
school leaving age 
Yes 46 50 
No 35 30 
Home ownership 
Own home outright 
or with mortgage 60 58 
 
Rent from a local 
authority or private 
sector 
21 22 
   
                 *: P < 0.1  
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Table 3 Description of TTO values for EQ-5D and EQ-5D+Sleep states 
 Health state N Mean Std. Deviation Minimum    Maximum 
EQ-5D 33333 81 -0.23 0.52 -0.98 0.99 
 32323 41 0.03 0.61 -0.98 1.00 
 33132 40 0.09 0.56 -0.98 1.00 
 11233* 41 0.18 0.60 -0.88 1.00 
 21331 41 0.24 0.57 -0.88 0.99 
 31112 41 0.29 0.63 -0.98 1.00 
 32221 40 0.32 0.58 -0.93 1.00 
 31211 41 0.38 0.61 -0.98 1.00 
 23222 41 0.40 0.51 -0.98 1.00 
 13213 40 0.40 0.51 -0.88 1.00 
 23311 41 0.43 0.52 -0.88 1.00 
 22232 40 0.44 0.51 -0.88 1.00 
 22113 41 0.46 0.53 -0.93 1.00 
 13121 40 0.54 0.47 -0.93 1.00 
 21123 40 0.57 0.42 -0.73 1.00 
 12131 40 0.58 0.41 -0.88 1.00 
 11322 40 0.60 0.42 -0.98 1.00 
 12312 41 0.61 0.35 -0.88 1.00 
  Total 770 0.32 0.58 -0.98 1.00 
EQ-5D 
+Sleep 333333 
 
78 -0.23 0.45 -0.98 0.63 
 
331322 40 0.17 0.49 -0.93 0.99 
 322232 38 0.23 0.47 -0.98 1.00 
 223313 38 0.28 0.48 -0.93 1.00 
 
222321 39 0.31 0.50 -0.93 1.00 
 321111 38 0.39 0.43 -0.93 1.00 
 231131 38 0.39 0.48 -0.98 1.00 
 
312113 38 0.39 0.47 -0.93 1.00 
 313221 40 0.40 0.46 -0.83 1.00 
 232212 39 0.40 0.50 -0.88 1.00 
 121233 38 0.44 0.42 -0.98 1.00 
 133211 40 0.46 0.45 -0.73 1.00 
 
112331* 40 0.49 0.47 -0.83 1.00 
 132123 40 0.55 0.45 -0.63 1.00 
 
123122 38 0.59 0.30 -0.48 1.00 
 213132 40 0.60 0.31 -0.53 1.00 
 111312 40 0.72 0.30 -0.38 1.00 
 211223 40 0.76 0.32 -0.48 1.00 
 Total 742 0.38 0.50 -0.98 1.00 
                Paired health states are in bold.  
  * Significant difference between the matched health states (p< 0.1) using t-test 
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Table 4  Random effects models for EQ-5D and EQ-5D+Sleep health states 
Dimensions & levels Main effects model Main effects  model with 
covariants 
 
EQ-5D 
(E1) 
EQ-
5D+Sleep 
(S1) 
Z score 
(E1) 
vs.(S1) 
EQ-5D 
(E2) 
EQ-5D+Sleep 
(S2) 
Constant  0.281** 0.146** 1.659       -0.423      0.103 
Mobility      
2             0.034 0.065** -0.674       0.026      0.054* 
3  0.315** 0.307**  0.185   0.292**      0.297** 
Self-care      
2            -0.017 0.141**   -3.038** -0.010      0.131** 
3   0.122** 0.259**   -3.172**    0.133**      0.262** 
Usual activity      
2             0.057* 0.073** -0.364   0.064**      0.072** 
3  0.108** 0.137** -0.658   0.096**      0.137** 
Pain/discomfort      
2 0.059*      0.042 0.368   0.075**      0.045 
3  0.242** 0.208** 0.761   0.260**      0.209** 
Anxiety/depresión      
2             0.008     -0.005 0.292 0.018      0.001 
3  0.168** 0.130** 0.910    0.176**      0.127 
Sleep      
2 -     -0.049* - -      -0.052* 
3 -      0.036 - -       0.036 
Female - - - 0.056      -0.105 
Age   -   
26-35 - - - -0.019      -0.205 
36-45 - - - -0.160      -0.333* 
46-55 - - - -0.055      -0.392** 
56-65 - - - 0.072      -0.379* 
66- - - - 0.070       -0.178 
Renting home   - -0.034       -0.078 
No education after mínimum 
School leaving age - - 
 
- 
-0.170       -0.143 
Self-reported morbidity      
2 - - - -0.051       0.024 
3 - - - - - 
Self-reported self-care      
2 - - - 0.010       -0.089 
3 - - - - - 
Self-reported usual activities  -     
2 - - - 0.027 0.608 
3 - - - 0.272 0.469 
Self-reported pain/discomfort      
2 - - - 0.303 0.265 
3 - - - 0.194 0.191 
Self-report anxiety/depression      
2 - - - 0.560 -0.313 
3 - - - 0.260 -0.302 
Self-reported sleep      
2 - - - -0.131 0.096 
3 -  - -0.016 0.118 
Adjusted R2 0.174 0.256 n/a 0.280 0.344 
 
              Note :  Dependent variable disutility =  1 ± tto. 
* p<0.1                   **p<0.05 
 
